#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2514	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2902	205.9	0	.	n	.	0	C451T	SNP	451	451	C	1082	1082	T	294	T,C,G	220,53,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2514	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2902	205.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1815	1815	C	246	C,T	234,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2514	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2902	205.9	0	HET	.	.	.	C207T,G	.	207	207	C	838	838	C	224	C,T,G	164,37,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3634	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4408	200.4	0	.	n	.	0	T695C	SNP	695	695	T	1474	1474	C	223	C,T,A	209,1,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3634	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4408	200.4	0	.	n	.	0	A1638G	SNP	1638	1638	A	2417	2417	G	222	G,T	216,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3634	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4408	200.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2750	2750	C	260	C,T,A	241,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3634	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4408	200.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2824	2824	A	261	A,C	253,2	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3634	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4408	200.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	3376	3376	C	209	C	206	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	240	folP	855	855	100.0	folP.l6.c4.ctg.1	2122	25.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1478	1480	AGC	19;19;19	A;G;C	18;18;18	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	448	gyrA	2751	2751	99.82	gyrA.l15.c17.ctg.1	3162	30.9	0	.	p	.	0	D814Y	NONSYN	2440	2442	GAT	2548	2550	TAT	14;14;14	T,G,A;A;T	1,11,1;12;14	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	448	gyrA	2751	2751	99.82	gyrA.l15.c17.ctg.1	3162	30.9	1	SNP	p	S91F	1	.	.	271	273	TTC	379	381	TTC	28;28;28	T;T;C,T	28;28;26,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	448	gyrA	2751	2751	99.82	gyrA.l15.c17.ctg.1	3162	30.9	1	SNP	p	G95N	0	.	.	283	285	GGC	391	393	GGC	30;30;30	G;G;C	30;30;28	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	448	gyrA	2751	2751	99.82	gyrA.l15.c17.ctg.1	3162	30.9	1	SNP	p	D95G	1	.	.	283	285	GGC	391	393	GGC	30;30;30	G;G;C	30;30;28	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	204	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	2119	23.5	1	SNP	p	G45D	0	.	.	133	135	GGC	1000	1002	GGC	49;49;49	G;G;C	41;41;42	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	152	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c4.ctg.1	1181	24.9	0	.	n	.	0	A197.	DEL	197	197	A	740	740	A	52	A	51	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	672	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3518	45.7	1	SNP	p	D86N	0	.	.	256	258	GAC	884	886	GAC	44;44;47	G;A,C;C,G	30;28,1;36,1	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	672	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3518	45.7	1	SNP	p	R87I	0	.	.	259	261	CGT	887	889	CGT	47;47;47	C;G;T,G	37;33;37,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	672	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3518	45.7	1	SNP	p	R87W	0	.	.	259	261	CGT	887	889	CGT	47;47;47	C;G;T,G	37;33;37,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	672	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3518	45.7	1	SNP	p	S87R	1	.	.	259	261	CGT	887	889	CGT	47;47;47	C;G;T,G	37;33;37,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	672	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3518	45.7	1	SNP	p	S88P	0	.	.	262	264	TCC	890	892	TCC	47;46;46	T;C;C,T	40;38;41,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	512	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2880	40.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1439	1441	GGC	42;43;43	G;G,T;C	39;36,1;33	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	283	510	penA	1746	1746	100.0	penA.l15.c4.ctg.1	3075	39.1	1	SNP	p	A311V	0	.	.	931	933	GCC	1697	1699	GCC	70;70;70	G;C;C,A	68;68;67,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	283	510	penA	1746	1746	100.0	penA.l15.c4.ctg.1	3075	39.1	1	SNP	p	I312M	1	.	.	934	936	ATG	1700	1702	ATG	70;71;72	A;T,G;G,T	68;66,3;66,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	283	510	penA	1746	1746	100.0	penA.l15.c4.ctg.1	3075	39.1	1	SNP	p	V316T	1	.	.	946	948	ACC	1712	1714	ACC	69;69;69	A,C;C,A;C	64,1;65,1;66	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	283	510	penA	1746	1746	100.0	penA.l15.c4.ctg.1	3075	39.1	1	SNP	p	T316P	0	.	.	946	948	ACC	1712	1714	ACC	69;69;69	A,C;C,A;C	64,1;65,1;66	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	283	510	penA	1746	1746	100.0	penA.l15.c4.ctg.1	3075	39.1	1	SNP	p	T483S	0	.	.	1447	1449	ACC	2213	2215	ACC	40;39;39	A;C,A;C	35;31,1;38	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	283	510	penA	1746	1746	100.0	penA.l15.c4.ctg.1	3075	39.1	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2267	2269	GCG	38;39;40	G;C,G;G,C,T	34;30,2;34,1,1	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	283	510	penA	1746	1746	100.0	penA.l15.c4.ctg.1	3075	39.1	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2267	2269	GCG	38;39;40	G;C,G;G,C,T	34;30,2;34,1,1	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	283	510	penA	1746	1746	100.0	penA.l15.c4.ctg.1	3075	39.1	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2390	2392	GGT	36;36;36	G;G,T;T	35;30,4;34	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	283	510	penA	1746	1746	100.0	penA.l15.c4.ctg.1	3075	39.1	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2399	2401	AGC	33;33;33	A;G;C,G	18;23;19,1	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	283	510	penA	1746	1746	100.0	penA.l15.c4.ctg.1	3075	39.1	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2417	2419	CCG	37;37;36	C,G;C,G;G,C,A	27,1;22,3;24,3,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	708	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3791	44.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1971	1973	CCG	54;54;54	C,T;C;G,C,T	42,1;47;36,3,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	787	288	porA	1146	1146	99.91	porA.l15.c17.ctg.1	2419	28.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	1590	1590	A	27	A	20	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	382	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2657	34.1	0	.	p	.	0	G210R	NONSYN	628	630	GGA	1269	1271	AGA	52;52;52	A;G;A	48;48;48	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	382	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2657	34.1	0	.	p	.	0	S217G	NONSYN	649	651	AGT	1290	1292	GGT	46;46;48	G;G,C;T	40;41,1;42	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	382	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2657	34.1	1	SNP	p	G120K	1	.	.	358	360	AAG	999	1001	AAG	58;57;59	A,C;A;G	53,3;56;56	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	382	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2657	34.1	1	SNP	p	N121D	0	.	.	361	363	AAC	1002	1004	AAC	59;59;59	A,G,C;A;CAA,CA	52,3,1;56;44,2	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	382	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2657	34.1	1	SNP	p	A121N	1	.	.	361	363	AAC	1002	1004	AAC	59;59;59	A,G,C;A;CAA,CA	52,3,1;56;44,2	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1376	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5493	60.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	200	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1832	26.6	1	SNP	p	V57M	1	.	.	169	171	ATG	954	956	ATG	47;48;48	A;T;G	46;48;48	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
